AerSale Corporation Common Stock (ASLE)
CyclicalFairStock Score: 43/100 — MIXED
Key Financials
| Current Price | $6.4 |
| Market Cap | $324M |
| P/E Ratio | 30.48 |
| ROE | 2.51% |
| Dividend Yield | —% |
| Sector | Industrials |
Strengths
- Generates $32 million in annual free cash flow (9.8% yield on market cap)
- Strong Piotroski F-Score of 7/9 indicating robust financial health across profitability, leverage, and efficiency metrics
- Conservative balance sheet with debt-to-equity of just 0.34, providing financial flexibility
Concerns
- Elevated P/E of 37.8x prices in substantial future growth that may not materialize
- Revenue declining at 4.0% year-over-year signals potential demand weakness or market share loss
- Altman Z-Score of 1.8 places it in the financial distress zone—elevated bankruptcy risk
- No meaningful dividend despite modest growth—total return depends entirely on multiple expansion
AI Analysis
AerSale Corporation Common Stock is a micro-cap industrials company valued at $324 million. The business generates $335 million in annual revenue with a 1.6% net margin and $32 million in free cash flow. From a quality standpoint, AerSale shows solid Piotroski F-Score of 7/9 and distressed Altman Z-Score of 1.8 warrants caution. On valuation, the stock is trading at a premium 37.8x earnings, with trades above its Graham Number with a negative 14% margin. Growth dynamics show revenue growing at -4.0% and profit growth of 99.7%. Our composite FairStock Score of 43/100 reflects below-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $32 million in annual free cash flow (9.8% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
At 38x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer